Yuyu Pharma, Inc. (KRX:000220)
4,305.00
+40.00 (0.94%)
At close: Sep 3, 2025
Yuyu Pharma Revenue
Yuyu Pharma had revenue of 35.85B KRW in the quarter ending June 30, 2025, with 8.05% growth. This brings the company's revenue in the last twelve months to 135.32B, up 0.03% year-over-year. In the year 2024, Yuyu Pharma had annual revenue of 133.15B, down -2.96%.
Revenue (ttm)
135.32B
Revenue Growth
+0.03%
P/S Ratio
0.50
Revenue / Employee
532.75M
Employees
254
Market Cap
67.86B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 133.15B | -4.06B | -2.96% |
Dec 31, 2023 | 137.21B | -1.67B | -1.20% |
Dec 31, 2022 | 138.88B | 23.23B | 20.08% |
Dec 31, 2021 | 115.66B | 17.54B | 17.87% |
Dec 31, 2020 | 98.12B | 7.24B | 7.97% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |